nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—Hepatitis cholestatic—Glyburide—gestational diabetes	0.0545	0.1	CcSEcCtD
Octreotide—Cholestasis—Glyburide—gestational diabetes	0.0289	0.0533	CcSEcCtD
Octreotide—Coagulopathy—Glyburide—gestational diabetes	0.0282	0.052	CcSEcCtD
Octreotide—Jaundice cholestatic—Glyburide—gestational diabetes	0.025	0.0461	CcSEcCtD
Octreotide—Hyperbilirubinaemia—Glyburide—gestational diabetes	0.0241	0.0445	CcSEcCtD
Octreotide—SSTR4—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.0211	0.046	CbGpPWpGaD
Octreotide—SSTR4—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.0196	0.0427	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—GCK—gestational diabetes	0.0185	0.0403	CbGpPWpGaD
Octreotide—Deafness—Glyburide—gestational diabetes	0.0178	0.0328	CcSEcCtD
Octreotide—Visual disturbance—Glyburide—gestational diabetes	0.0168	0.031	CcSEcCtD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.0168	0.0366	CbGpPWpGaD
Octreotide—Arthritis—Glyburide—gestational diabetes	0.0164	0.0302	CcSEcCtD
Octreotide—Hypoglycaemia—Glyburide—gestational diabetes	0.0163	0.0301	CcSEcCtD
Octreotide—SSTR3—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.016	0.0349	CbGpPWpGaD
Octreotide—SSTR1—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.0153	0.0335	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—GCK—gestational diabetes	0.0151	0.033	CbGpPWpGaD
Octreotide—SSTR3—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.0148	0.0324	CbGpPWpGaD
Octreotide—SSTR1—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.0142	0.031	CbGpPWpGaD
Octreotide—Abdominal distension—Glyburide—gestational diabetes	0.0139	0.0256	CcSEcCtD
Octreotide—SSTR5—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.0136	0.0297	CbGpPWpGaD
Octreotide—Pancreatitis—Glyburide—gestational diabetes	0.0135	0.0249	CcSEcCtD
Octreotide—Sweating increased—Glyburide—gestational diabetes	0.0134	0.0247	CcSEcCtD
Octreotide—SSTR1—SIDS Susceptibility Pathways—AR—gestational diabetes	0.0131	0.0287	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—MTNR1B—gestational diabetes	0.0128	0.0279	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.0127	0.0277	CbGpPWpGaD
Octreotide—SSTR5—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.0126	0.0275	CbGpPWpGaD
Octreotide—SSTR2—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.0125	0.0274	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.0122	0.0266	CbGpPWpGaD
Octreotide—Jaundice—Glyburide—gestational diabetes	0.012	0.0221	CcSEcCtD
Octreotide—SSTR2—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.0116	0.0254	CbGpPWpGaD
Octreotide—Hepatitis—Glyburide—gestational diabetes	0.011	0.0203	CcSEcCtD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.0108	0.0236	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—AR—gestational diabetes	0.0107	0.0235	CbGpPWpGaD
Octreotide—Visual impairment—Glyburide—gestational diabetes	0.0106	0.0196	CcSEcCtD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.00997	0.0218	CbGpPWpGaD
Octreotide—Alopecia—Glyburide—gestational diabetes	0.00974	0.018	CcSEcCtD
Octreotide—SSTR3—GPCR ligand binding—MTNR1B—gestational diabetes	0.00967	0.0211	CbGpPWpGaD
Octreotide—Malnutrition—Glyburide—gestational diabetes	0.00959	0.0177	CcSEcCtD
Octreotide—Erythema—Glyburide—gestational diabetes	0.00959	0.0177	CcSEcCtD
Octreotide—SSTR1—GPCR ligand binding—MTNR1B—gestational diabetes	0.00927	0.0203	CbGpPWpGaD
Octreotide—Vision blurred—Glyburide—gestational diabetes	0.00904	0.0167	CcSEcCtD
Octreotide—Tremor—Glyburide—gestational diabetes	0.00899	0.0166	CcSEcCtD
Octreotide—Anaemia—Glyburide—gestational diabetes	0.00887	0.0163	CcSEcCtD
Octreotide—Convulsion—Glyburide—gestational diabetes	0.00831	0.0153	CcSEcCtD
Octreotide—SSTR5—GPCR ligand binding—MTNR1B—gestational diabetes	0.00822	0.018	CbGpPWpGaD
Octreotide—Myalgia—Glyburide—gestational diabetes	0.00817	0.0151	CcSEcCtD
Octreotide—Arthralgia—Glyburide—gestational diabetes	0.00817	0.0151	CcSEcCtD
Octreotide—Oedema—Glyburide—gestational diabetes	0.00783	0.0144	CcSEcCtD
Octreotide—Shock—Glyburide—gestational diabetes	0.0077	0.0142	CcSEcCtD
Octreotide—Nervous system disorder—Glyburide—gestational diabetes	0.00768	0.0142	CcSEcCtD
Octreotide—Thrombocytopenia—Glyburide—gestational diabetes	0.00767	0.0141	CcSEcCtD
Octreotide—SSTR2—GPCR ligand binding—MTNR1B—gestational diabetes	0.00759	0.0166	CbGpPWpGaD
Octreotide—Hyperhidrosis—Glyburide—gestational diabetes	0.00757	0.014	CcSEcCtD
Octreotide—MPO—IL23-mediated signaling events—TNF—gestational diabetes	0.00757	0.0165	CbGpPWpGaD
Octreotide—Anorexia—Glyburide—gestational diabetes	0.00746	0.0138	CcSEcCtD
Octreotide—SSTR4—GPCR downstream signaling—MTNR1B—gestational diabetes	0.00721	0.0158	CbGpPWpGaD
Octreotide—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.00713	0.0132	CcSEcCtD
Octreotide—Paraesthesia—Glyburide—gestational diabetes	0.00703	0.013	CcSEcCtD
Octreotide—Dyspnoea—Glyburide—gestational diabetes	0.00698	0.0129	CcSEcCtD
Octreotide—Dyspepsia—Glyburide—gestational diabetes	0.00689	0.0127	CcSEcCtD
Octreotide—Decreased appetite—Glyburide—gestational diabetes	0.00681	0.0125	CcSEcCtD
Octreotide—Gastrointestinal disorder—Glyburide—gestational diabetes	0.00676	0.0125	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—MTNR1B—gestational diabetes	0.00655	0.0143	CbGpPWpGaD
Octreotide—Feeling abnormal—Glyburide—gestational diabetes	0.00645	0.0119	CcSEcCtD
Octreotide—Gastrointestinal pain—Glyburide—gestational diabetes	0.0064	0.0118	CcSEcCtD
Octreotide—Urticaria—Glyburide—gestational diabetes	0.00622	0.0115	CcSEcCtD
Octreotide—Abdominal pain—Glyburide—gestational diabetes	0.00619	0.0114	CcSEcCtD
Octreotide—MPO—Vitamin B12 Metabolism—TNF—gestational diabetes	0.00585	0.0128	CbGpPWpGaD
Octreotide—Hypersensitivity—Glyburide—gestational diabetes	0.00577	0.0106	CcSEcCtD
Octreotide—Asthenia—Glyburide—gestational diabetes	0.00562	0.0104	CcSEcCtD
Octreotide—Pruritus—Glyburide—gestational diabetes	0.00554	0.0102	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—MTNR1B—gestational diabetes	0.00547	0.0119	CbGpPWpGaD
Octreotide—Diarrhoea—Glyburide—gestational diabetes	0.00536	0.00988	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—MTNR1B—gestational diabetes	0.00524	0.0114	CbGpPWpGaD
Octreotide—Vomiting—Glyburide—gestational diabetes	0.00498	0.00918	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—MTNR1B—gestational diabetes	0.00496	0.0108	CbGpPWpGaD
Octreotide—Rash—Glyburide—gestational diabetes	0.00494	0.0091	CcSEcCtD
Octreotide—Dermatitis—Glyburide—gestational diabetes	0.00493	0.00909	CcSEcCtD
Octreotide—Headache—Glyburide—gestational diabetes	0.0049	0.00904	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—LEPR—gestational diabetes	0.00489	0.0107	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—TNF—gestational diabetes	0.00476	0.0104	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—MTNR1B—gestational diabetes	0.00476	0.0104	CbGpPWpGaD
Octreotide—Nausea—Glyburide—gestational diabetes	0.00465	0.00858	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—MTNR1B—gestational diabetes	0.00465	0.0102	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—TNF—gestational diabetes	0.00437	0.00954	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—MTNR1B—gestational diabetes	0.00429	0.00937	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—MTNR1B—gestational diabetes	0.00422	0.00922	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—MTNR1B—gestational diabetes	0.00389	0.00851	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MTNR1B—gestational diabetes	0.00387	0.00845	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—TNF—gestational diabetes	0.00378	0.00827	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—RBP4—gestational diabetes	0.00377	0.00824	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—LEPR—gestational diabetes	0.00371	0.0081	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—TNF—gestational diabetes	0.00358	0.00781	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—LEPR—gestational diabetes	0.00356	0.00777	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—LEPR—gestational diabetes	0.00315	0.00689	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MTNR1B—gestational diabetes	0.00293	0.00641	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—LEPR—gestational diabetes	0.00291	0.00636	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—RBP4—gestational diabetes	0.00286	0.00624	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MTNR1B—gestational diabetes	0.00281	0.00614	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—RBP4—gestational diabetes	0.00274	0.00598	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MTNR1B—gestational diabetes	0.00249	0.00545	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RBP4—gestational diabetes	0.00243	0.00531	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MTNR1B—gestational diabetes	0.0023	0.00503	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RBP4—gestational diabetes	0.00224	0.0049	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—LEP—gestational diabetes	0.00172	0.00376	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—FGF2—gestational diabetes	0.00131	0.00285	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—LEP—gestational diabetes	0.0013	0.00285	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—LEP—gestational diabetes	0.00125	0.00273	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—LEP—gestational diabetes	0.00111	0.00242	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—LEP—gestational diabetes	0.00102	0.00223	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—FGF2—gestational diabetes	0.00099	0.00216	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—FGF2—gestational diabetes	0.000949	0.00207	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—FGF2—gestational diabetes	0.000841	0.00184	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—FGF2—gestational diabetes	0.000776	0.0017	CbGpPWpGaD
